
VXLLF
Healthcare · Biotechnology · $60,158 market cap
$0.01510.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 28, 2024 | After the close | — | -0.00 | — |
| May 30, 2024 | After the close | — | -0.00 | — |
| Sep 30, 2021 | Time not confirmed | — | -0.00 | — |
| Jun 30, 2021 | Time not confirmed | — | -0.00 | — |
| Mar 31, 2021 | Time not confirmed | — | -0.00 | — |
| Dec 31, 2020 | Time not confirmed | — | -0.00 | — |
| Sep 30, 2020 | Time not confirmed | — | -0.00 | — |
| Jun 30, 2020 | Time not confirmed | — | -0.00 | — |
| Mar 31, 2020 | Time not confirmed | — | -0.00 | — |
| Dec 31, 2019 | Time not confirmed | — | -0.00 | — |
| Sep 30, 2019 | Time not confirmed | — | -0.00 | — |
| Jun 30, 2019 | Time not confirmed | — | -0.00 | — |
| Mar 31, 2019 | Time not confirmed | — | -0.00 | — |
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company is headquartered in Toronto, Canada.
| Time not confirmed |
| — |
| -0.00 |
| — |
| Sep 30, 2018 | Time not confirmed | — | -0.00 | — |
| Jun 30, 2018 | Time not confirmed | — | -0.00 | — |
| Mar 31, 2018 | Time not confirmed | — | -0.00 | — |